Olema Pharmaceuticals, Inc. (OLMA)
13.67
-0.45
(-3.19%)
USD |
NASDAQ |
Mar 27, 16:00
13.67
0.00 (0.00%)
After-Hours: 17:07
Olema Pharmaceuticals Free Cash Flow : -146.72M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -266.00M |
| EyePoint Plc | -243.39M |
| CytomX Therapeutics, Inc. | -75.81M |
| Corvus Pharmaceuticals, Inc. | -32.97M |
| Protagonist Therapeutics, Inc. | 56.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.33M |
| Cash from Investing (Quarterly) | -162.18M |
| Cash from Financing (Quarterly) | 213.55M |
| Free Cash Flow Per Share (Quarterly) | -0.4197 |
| Free Cash Flow to Equity (Quarterly) | -38.04M |
| Free Cash Flow to Firm (Quarterly) | -38.33M |
| Free Cash Flow Yield | -12.34% |